IN172887B - - Google Patents

Info

Publication number
IN172887B
IN172887B IN85BO1991A IN172887B IN 172887 B IN172887 B IN 172887B IN 85BO1991 A IN85BO1991 A IN 85BO1991A IN 172887 B IN172887 B IN 172887B
Authority
IN
India
Prior art keywords
enzyme
link
hypohalite
peroxidase
vehicles
Prior art date
Application number
Other languages
English (en)
Inventor
Thomas Stewart Beggs
Paul James Davis
Original Assignee
Lever Hindustan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909006329A external-priority patent/GB9006329D0/en
Priority claimed from GB909021671A external-priority patent/GB9021671D0/en
Application filed by Lever Hindustan Ltd filed Critical Lever Hindustan Ltd
Publication of IN172887B publication Critical patent/IN172887B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
IN85BO1991 1990-03-21 1991-03-21 IN172887B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909006329A GB9006329D0 (en) 1990-03-21 1990-03-21 Cell killing
GB909021671A GB9021671D0 (en) 1990-10-05 1990-10-05 Delivery of agents

Publications (1)

Publication Number Publication Date
IN172887B true IN172887B (da) 1993-12-25

Family

ID=26296816

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85BO1991 IN172887B (da) 1990-03-21 1991-03-21

Country Status (8)

Country Link
EP (1) EP0451972B1 (da)
JP (1) JPH0584073A (da)
AT (1) ATE138579T1 (da)
AU (1) AU642980B2 (da)
CA (1) CA2038579C (da)
DE (1) DE69119817T2 (da)
ES (1) ES2088463T3 (da)
IN (1) IN172887B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143053T1 (de) * 1992-03-06 1996-10-15 Creagen Inc Pathogen-gerichtete biokatalisatoren
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
US5665333A (en) * 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
WO1997023241A1 (en) * 1995-12-21 1997-07-03 Quest International B.V. Particle compositions
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
PT1811036E (pt) 1999-02-22 2011-07-11 Univ Georgetown Imunolipossomas dirigidos por fragmento de anticorpo para distribuição sistémica de genes
US9034329B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
JP2003509438A (ja) * 1999-09-16 2003-03-11 ユニリーバー・ナームローゼ・ベンノートシヤープ 抗フケ剤の送達システム
FR2803199B1 (fr) * 1999-12-29 2002-05-10 Jean Dominique Dana Procede de transformation des sucres alimentaires cariogenes en produits neutres acariogenes ou cariostatiques et composition pour la mise en oeuvre
EP1408996B1 (en) * 2001-04-02 2008-09-10 Georgetown University A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
BRPI0617481A2 (pt) * 2005-10-21 2011-07-26 Danisco composiÇço que compreende um sistema enzimÁtico acoplado
AU2007257357B2 (en) 2006-05-15 2010-08-26 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
KR20130132936A (ko) 2010-12-20 2013-12-05 이 아이 듀폰 디 네모아 앤드 캄파니 구강 관리 제품에 사용하기 위한 효소에 의한 과산 생성

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578265A (en) * 1981-08-13 1986-03-25 Laclede Professional Products, Inc. Di-enzymatic dentifrice
EP0271180B2 (en) * 1986-08-18 1997-06-18 The Dow Chemical Company Starburst conjugates
AU4402589A (en) * 1988-09-28 1990-04-18 Ideon Corporation Combination enzyme immunotherapeutics
AU5546090A (en) * 1989-06-30 1991-01-17 Brunswick Corporation Antibody-lactate oxidase conjugates
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
AU5544090A (en) * 1990-04-26 1991-11-11 Ringdal Patenter A/S Activating unit for weapon

Also Published As

Publication number Publication date
AU7299791A (en) 1991-10-03
CA2038579C (en) 1998-06-23
EP0451972B1 (en) 1996-05-29
ATE138579T1 (de) 1996-06-15
CA2038579A1 (en) 1991-09-22
DE69119817T2 (de) 1996-10-31
JPH0584073A (ja) 1993-04-06
EP0451972A1 (en) 1991-10-16
ES2088463T3 (es) 1996-08-16
AU642980B2 (en) 1993-11-04
DE69119817D1 (de) 1996-07-04

Similar Documents

Publication Publication Date Title
IN172887B (da)
TW290544B (da)
GB2209939B (en) The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
DE69428290D1 (de) Derivate von alpha-hordothionin mit höherem behalt an lysin
AU9737398A (en) Alpha-amylase mutants
ES2164731T3 (es) Suspension acuosa tixotropica de agentes fitoprotectores.
GR852493B (da)
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
BR9502522A (pt) Composiçao concentrada em suspensao
DK0630408T3 (da) Fremstilling af $i(Aspergillus niger catalase-R)
MY105128A (en) Bu-3608 derivatives.
AU578065B2 (en) Stabilized enzyme conjugate compositions
IN172886B (da)
PH24796A (en) A method of preventing aids by using a didioxynucleoside analog
AU7037987A (en) Oxygen generating herbicides synergized with detoxifying enzyme inhibitor
GR3006732T3 (da)
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
ZA846388B (en) Alpha-allenic-alpha-amino acids
CA2022321A1 (en) Granular laundry detergent compositions having improved solubility
NO903506D0 (no) Distraksjonsapparat for aa opprettholde orientering av brukket ledd.
AU102461S (en) A draft frame